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Problems at the pump? Findings of a recent federal report on oxygenated fuels do little to dispel debate
overthe health effects of MTBE.
substance of the Report on Carcinogens, the
process by which the report is prepared and
reviewed is also being broadened to promote
more public input.
Fueling the Debate
Touted as a way to protect public health by
decreasing carbon monoxide (CO) emis-
sions from automobiles, oxygenated fuels
containing methyl tertiary butyl ether
(MTBE) have been blamed anecdotally for
causing headaches, dizziness, eye irritation,
burning of the nose and throat, disorienta-
tion, and nausea in motorists. In addition,
studies have shown that MTBE can cause
cancer in rats and mice, though it appears to
be a less potent carcinogen than many ofthe
other chemicals found in gasoline and
exhaust. Most recently, wells that supply
drinking water to Santa Monica, California,
were shut down due to high levels ofMTBE
contamination.
Concerns about the health risks of
MTBE, combined with doubts about its
ability to significantly lower CO emissions,
have caused many to question the usefulness
ofthe chemical as a fuel additive. However,
proponents point to decreases in nation-
wide CO levels as evidence that the 1990
amendments to the Clean Air Act, which
sparked the widespread use of MTBE by
requiring the use ofoxygenated fuels in areas
with high CO levels, have led to greatly
improved airquality.
Disagreement over the safety and practi-
cality of using MTBE in fuels spurred the
EPA to request that the White House
National Science and Technology Council
review studies done on oxygenated fuels and
compile the Interagency Assessment of
Oxygenated Fuels, which was published in
June 1997. The report considers the effects
that using MTBE-treated fuel may have on
air quality, water quality, fuel economy,
engineperformance, andhuman health.
However, the report does not make any
policy recommendations about the future of
MTBE as a fuel additive. Ronald Melnick, a
toxicologist with the NIEHS who con-
tributed to the interagency report, says, "As
far as the total picture ofexposure and health
effects of oxygenated fuels versus nonoxy-
genated fuels, there is just not enough evi-
dence right now to draw any definitive con-
clusion on comparative cancer risk."
As for the effectiveness of MTBE, the
authors ofthe report did find evidence that
the chemical, under certain conditions, can
decrease CO levels, but they also point out
that its performance has not met expecta-
tions. "The effectiveness of MTBE was
based on models that predicted a 25%
decline in CO emissions, which wejust have
not seen," says Melnick. "CO emissions are
decreasing, but it's incorrect to say that this
is only a result ofusing oxygenated fuels. A
large part ofthe decrease is due to improved
emission control technology." The report
notes that MTBE also cuts other harmful
emissions such as benzene and possibly 1,3-
butadiene, which is 100 times more carcino-
genic than the additive, but that it increases
emissions of aldehydes such as the metabo-
lite formaldehyde, which the EPA and the
IARC have labeled a genotoxin and proba-
ble human carcinogen.
Howsuch changes in emissions and in the
composition offuel vaporswill affect motorists
is still uncertain, the report concludes.
"Complaints have been raised and have not
been dismissed about acute health effects like
dizziness, headaches, [and] nausea," says
Melnick. "There seems to be some consistency
in these reports." But the authors ofthe intera-
gencyreportcould notfindenoughevidence to
support the contention that MTBE, as used in
the winter oxygenated fuels program, is signifi-
cantly increasing these effects at levels over
backgroundlevels.
According to the report, the interagency
assessment "found that chronic noncancer
health effects (neurological, developmental,
or reproductive) would not likely occur at
environmental or occupational exposures to
MTBE." However, inhalation ofMTBE has
been shown to cause cancer in multiple organ
sites in rats and mice. "The EPA is working
on a health advisory on MTBE that will be
issued in the near future," says Robert Hitzig,
the technical lead for the EPA's Office of
Underground Storage Tanks. "But it's uncer-
tain now whether [MTBE] will be classified
as a possible human carcinogen, a probable
human carcinogen, or what its classification
will be." However, the interagency report
points out that the cancer risk to humans
posed byMTBEissimilarorslightlyless than
thatposed byuntreated gasolinevapors.
Though the health effects of MTBE
ingestion are less understood than the effects
ofinhalation, the appearance ofthe additive
in drinking water across the nation has
caused concern over this route of exposure.
"MTBE absorbs weakly in soil and not very
biodegradable," explains Melnick, "so when
there are leakages from underground gasoline
storage tanks, it travels further in the ground
water and persists for long periods oftime."
Also, MTBE that enters the atmosphere
through exhaust and evaporation can fall to
earth and flow into surface water reservoirs
with precipitation. Recent studies found
MTBE in 7% ofurban storm water samples
and in 5% ofwell water samples from across
the United States. "The health hazards of
MTBE in water are debatable," says Hitzig,
"but it's not debatable that there areaesthetic
problems with it. MTBE has a very low taste
and smell threshold, so that ifit's in people's
water, theyprobablyknowit."
It is also unknown if the presence of
MTBE in water is taking a toll on aquatic
life. Studies so farhave focused onlyon water
used forhuman consumption, but the persis-
tence of the chemical in the environment
makes it of particular concern. Also, notes
Hitzig, "There's no way oftelling how much
MTBE has leaked into groundwater. There
have been over 300,000 confirmed releases
of petroleum from underground storage
tanks since 1988, but we don't know what
percentage ofthemhad MTBE in them."
MTBE, which is derived from methanol,
is now the mostwidelyused oxygenate in the
United States. From 1984 to 1995, produc-
tion has increased by about 26% annually,
with 8 billion kg produced in 1995.
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Essentially all of the MTBE produced or
imported in the United States is used in the
oxygenation of gasoline. Gasoline can con-
tain up to 15% MTBE byvolume.
In light of the concerns raised over the
use of MTBE, many wonder why the oxy-
genated fuel program was implemented
without further research being conducted
first. "Congress required the use of oxy-
genates in the Clean Air Act," says Hitzig.
"The EPA is simply following the statute
that was passed. There was a lot known
about the risks of MTBE at the time, but
maybe the people working on the legislation
didn't know [that]."
"A program should be evaluated for
[MTBE's] effectiveness as well as its health
effects before it is put into use," says Melnick.
"There are obviously serious questions about
MTBE's effectiveness and its role as an envi-
ronmental contaminant. So the question is,
arewe gainingsufficient benefits to make this
program worthwhile." Much more research
will be needed before this question may be
answeredwith anycertainty.
Telomerase Gene Identified
One more step toward understanding the
uncontrolled proliferation of immortal can-
cer cells was taken in August as two separate
groups identified the putative human telom-
erase gene for the first time. These results
were published almost simultaneously in the
scientificjournals Scienceand Cell.
The gene produces the enzyme necessary
to maintain telomeres, the structures at the
end ofeach chromosome. When cells divide
theylose, through the normal process ofpro-
liferation, a few ofthe special base pairs that
make up the telomeres. For most cells, this is
presumably part ofthe natural aging process
of the cell. When these base pairs run out,
the cell can no longer divide properly.
However, for several specialized normal
cells in the body it is imperative to be able
to continue to divide past the limits nor-
mally enforced by the length of the telom-
eres. Two examples include gamete cells,
which carry genetic material from one gen-
eration to the next, and the cells in a devel-
oping embryo. In the delicate mechanics of
the cell, the enzyme telomerase is turned on
and off as it is needed to maintain the
length ofthe telomeres.
In contrast to specialized cells, normal
cells do not express telomerase. In almost all
tumor cells, however, telomerase is
expressed. When telomerase is turned on
inappropriately, the cell can then become
immortal, meaning it can continue to divide
indefinitely. The discovery of the gene-
encoding part ofthe telomerase enzyme will
allow scientists to probe deeper into the
i-Ie
Cancer Bytes
All cancers, scientists have learned in the last 20 years, begin with a malfunction in the
genetic machinery ofa cell, causing it to duplicate itselfwithout restraint. Such knowl-
edge brings with it not only new hope for stopping these deadly diseases, but also a great
challenge for scientists-to discern the location and function ofthe culprit genes among
the over 100,000 in each human cell.
Now, a powerful new tool on theWorld Wide Web is making this task much more
feasible. The Cancer GenomeAnatomy Project (CGAP), which was launched inAugust
1997, provides scientists with data on the genes expressed in cancerous, precancerous,
and normal cells from several different tissues and organs. The site, located at
http://www.ncbi.nlm.nih.gov/ncicgap/, was developed
by the National Cancer Institute and the National
Library ofMedicine. Information accumulated there will
allow scientists to determine how gene expression
changes as cells become cancerous, and use this knowl-
edge to direct their research toward suspect genes or
their protein products.
Such research could lead to newways to stop malig-
nant tumors, but even iffulfillment ofthat goal remains
elusive, the genetic "fingerprints" in the CGAP gene
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index will serve other valuable functions. Using this information, doctors will be able to
determine ifcells are cancerous before a tumor forms by looking at what genes are being
expressed in them. This will allow treatment regimens to be started earlier, quite possi-
bly saving the lives ofmany patients. Doctors could also use this information to better
match treatments to patients by using genetics to distinguish cancers that look nearly
identical but respond differently to treatments.
Another goal ofthe CGAP is to promote the development ofnew technologies that
will add to the breadth of information available on the site. Current technology, for
example, makes it difficult to sequence the full lengths ofthe genes expressed in a cell,
so much ofthe CGAP database is made up ofexpressed sequence tags short sequences
from randomly isolated portions ofgenes that can be used to identity genes but that do
not necessarily contain all oftheir genetic information. To address this shortcoming, the
CGAP has made $2.5 million in grants available to researchers to develop methods to
efficiently map the full-length sequences ofall the genes expressed in cells. Other CGAP
grants support the development oftechnologies to scan the genomes ofcancer cells and
to evaluate molecular changes in tumor specimens.
From the CGAP home page, information on CGAP grants can be found by fol-
lowing the Information link on the left menu bar. Also on this menu bar is a link to a
description of one ofthe newest technologies being used to gather data for the CGAP
web site: clicking on the picture ofthe laser capture microdissection microscope brings
users to an account ofhow this tool allows scientists to isolate only a few cells ofinterest
from a tissue sample forgenetic analysis, rather than using larger specimens that may
contain several types ofcels.
Ryrent for the View LihrariPe link. al other links on the home naze take users to
other sites or to information on the methods used to create the
CGAP database. By following the View Libraries link, users are
led to the heart ofthe site, alist ofthe tissue libraries for which
CGAP genetic data are available. Choosing a link in this list will
lead to the genetic library page for that tissue. Each library page
includes information about t e tissue donor, a link to down oad
all of the expressed sequence tags observed in that library, and
brief descriptions of the genes found in the library that seem
particularly interesting (either because they code for a large por-
tion ofthe proteins found in the cell or because they are unique
to that library or tissue).
Each gene of interest on the library page is a link to another page of additional data
about that gene and the protein for whic it codes. The gene pages contain links to
maps that show the location ofthe gene on the human chromosomes, information on
other libraries in which the gene is expressed, and links to the DNA sequence that com-
poses that gene.
In many cases, the information on the CGAP site is incomplete-evidence ofthe
enormous amount ofwork that has yet to be done. But using the Internet to coordinate
the effort increases the likelihood that the CGAP will obtain its goal ofachieving a com-
prehensive molecular characterization of the broad spectrum of normal, precancerous,
and malignant cells.
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